Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology

NCT06392997 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2025-01-23

No results posted yet for this study

Summary

GynRAN is an international, multicentre, transversal, diagnostic and non-interventional study carried out in gynecology-obstetrics/gynecological oncology departments that aims to identify a diagnostic signature for gynecological pathologies by analyzing of coding and non-coding RNA contained in patients saliva.

The study population consists of patients with clinically symptomatic females with one or more of the gynecological pathologies (endometriosis, adenomyosis, ovarian cysts, fibroids, ovarian/cervical/uterine cancer) and asymptomatic females.

The patients concerned by the study will be managed without modification of the care pathway, nor modification of the therapeutic indications, nor modification of the diagnostic or follow-up examinations necessary according to the context, which are carried out according to the local recommendations.

Conditions

Interventions

DIAGNOSTIC_TEST

Saliva sample

Saliva sample

Sponsors & Collaborators

  • Monitoring Force Group

    collaborator INDUSTRY
  • ZIWIG

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-05
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06392997 on ClinicalTrials.gov